TRILC.E — Turk Ilac ve Serum Sanayi AS Cashflow Statement
0.000.00%
Last trade - 00:00- TRY3.87bn
- TRY5.50bn
- TRY2.57bn
- 29
- 38
- 56
- 32
Annual cashflow statement for Turk Ilac ve Serum Sanayi AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 33.3 | 37.1 | -81.7 | 153 | 72.4 |
| Depreciation | |||||
| Non-Cash Items | -4.12 | 10.5 | 168 | 120 | 542 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.7 | -127 | 48 | 95.8 | -1,002 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 33.2 | -71.7 | 148 | 408 | -378 |
| Capital Expenditures | -16.9 | -20.6 | -38.4 | -115 | -152 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 2.34 | 0.77 | — | — | -7.7 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -14.6 | -19.8 | -38.4 | -115 | -159 |
| Financing Cash Flow Items | -35.5 | -27 | -148 | -228 | -534 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -19.7 | 136 | -170 | -372 | 537 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.13 | 44.4 | -60.6 | -79.1 | -1.16 |